Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer  London, UK- 14th November 2024: Coronado Research announced today that Alexander McCormick has ...

The integration of AI in life science recruitment is already reshaping hiring processes by offering increased efficiency, ...

Talent consulting start-up, pobl., is thrilled to announce the addition of Lindsey Heer to its team. Lindsey, an experienced leader in medical communications, with foundations in the pharmaceutical ...

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today announces it has established a UK subsidiary, ...

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...

Proprietary 3D-Printing Resin Used by Glidewell Has Been Shown In Vitro to Produce Dentures With Antibacterial and Antifungal Effects NEWPORT BEACH, CA / ACCESSWIRE / November 14, 2024 / Glidewell, ...

SALT LAKE CITY, UT / ACCESSWIRE / November 14, 2024 / Cloud Storage Security (CSS), a leader in advanced threat detection and data loss prevention for cloud-native applications, today announced ...

Chiesi Group, an international biopharmaceutical company focused on research, has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune magazine, ranking ...

Terumo BCT announced a strategic partnership with Terumo Medical Products (Hangzhou) Co., Ltd., investing in its production facility located in the Qiantang District, Hangzhou, seeking to provide high ...

Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein antibody levels on average 16-fold higher than placebo after 3 immunizations 100% of patients receiving ACI-7104.056 responded ...

WELLINGTON, FL / ACCESSWIRE / November 14, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), formerly known as Preferred Commerce, today issued a statement to clarify its business focus and retract ...

Burlington, MA, USA – November 14, 2024 –SEKISUI Diagnostics’ microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK ...